nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifapentine—CYP3A4—Temozolomide—malignant glioma	0.199	1	CbGbCtD
Rifapentine—Rifampicin—CYP2B6—malignant glioma	0.0147	1	CrCbGaD
Rifapentine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00144	0.00183	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00143	0.00182	CbGpPWpGaD
Rifapentine—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00143	0.00181	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.00142	0.0018	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.00142	0.0018	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.0014	0.00178	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.0014	0.00178	CbGpPWpGaD
Rifapentine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00135	0.00172	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—ASMT—malignant glioma	0.00135	0.00172	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—BCAN—malignant glioma	0.00127	0.00161	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00124	0.00158	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.00123	0.00156	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.00121	0.00154	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.00116	0.00148	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00115	0.00147	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.00115	0.00146	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.00115	0.00146	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.00114	0.00145	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—RTEL1—malignant glioma	0.00111	0.00141	CbGpPWpGaD
Rifapentine—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.0011	0.0014	CbGpPWpGaD
Rifapentine—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.00108	0.00138	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.00107	0.00137	CbGpPWpGaD
Rifapentine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.00103	0.00131	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—IDH2—malignant glioma	0.00102	0.0013	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.00101	0.00128	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.001	0.00127	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000995	0.00127	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.000993	0.00126	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000986	0.00125	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CYP2B6—malignant glioma	0.000961	0.00122	CbGpPWpGaD
Rifapentine—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000959	0.00122	CbGpPWpGaD
Rifapentine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000941	0.0012	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.000931	0.00118	CbGpPWpGaD
Rifapentine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00089	0.00113	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—IDH1—malignant glioma	0.000879	0.00112	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—SPHK1—malignant glioma	0.00085	0.00108	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CYP2C18—malignant glioma	0.000833	0.00106	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000816	0.00104	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000809	0.00103	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000804	0.00102	CbGpPWpGaD
Rifapentine—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000795	0.00101	CbGpPWpGaD
Rifapentine—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000784	0.000997	CbGpPWpGaD
Rifapentine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00078	0.000992	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000764	0.000972	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.00076	0.000967	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000758	0.000964	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.00075	0.000954	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000696	0.000886	CbGpPWpGaD
Rifapentine—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000689	0.000876	CbGpPWpGaD
Rifapentine—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.000679	0.000864	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—GSTT1—malignant glioma	0.000674	0.000857	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000659	0.000839	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.00065	0.000827	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—COX8A—malignant glioma	0.000639	0.000812	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PTGS1—malignant glioma	0.000631	0.000803	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—BCHE—malignant glioma	0.000587	0.000747	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—SLC5A5—malignant glioma	0.00058	0.000737	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000572	0.000727	CbGpPWpGaD
Rifapentine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.00057	0.000726	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000567	0.000721	CbGpPWpGaD
Rifapentine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000565	0.000719	CbGpPWpGaD
Rifapentine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.00056	0.000713	CbGpPWpGaD
Rifapentine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000558	0.000709	CbGpPWpGaD
Rifapentine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000553	0.000703	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—ASMT—malignant glioma	0.000543	0.000691	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000533	0.000678	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—BCAN—malignant glioma	0.000511	0.000649	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.0005	0.000636	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000498	0.000633	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000481	0.000612	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—GSTP1—malignant glioma	0.000467	0.000594	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—COX8A—malignant glioma	0.000462	0.000587	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CAT—malignant glioma	0.000454	0.000578	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—NCOR1—malignant glioma	0.000429	0.000546	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—IDH2—malignant glioma	0.000412	0.000524	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000405	0.000515	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—COX8A—malignant glioma	0.0004	0.000509	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—ASMT—malignant glioma	0.000393	0.000499	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000392	0.000498	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000387	0.000492	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000374	0.000475	CbGpPWpGaD
Rifapentine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.00037	0.00047	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—BCAN—malignant glioma	0.000369	0.000469	CbGpPWpGaD
Rifapentine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000365	0.000464	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000357	0.000455	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—IDH1—malignant glioma	0.000354	0.00045	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—CAV1—malignant glioma	0.00035	0.000445	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—SPHK1—malignant glioma	0.000342	0.000436	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—ASMT—malignant glioma	0.00034	0.000432	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CYP2C18—malignant glioma	0.000336	0.000427	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000332	0.000423	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—COX8A—malignant glioma	0.000328	0.000418	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—COX8A—malignant glioma	0.000325	0.000414	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—BCAN—malignant glioma	0.00032	0.000407	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PIK3CG—malignant glioma	0.000319	0.000405	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PPARG—malignant glioma	0.000308	0.000391	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—IDH2—malignant glioma	0.000298	0.000378	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000291	0.00037	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PIK3CD—malignant glioma	0.00028	0.000356	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CYP2B6—malignant glioma	0.00028	0.000356	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—ASMT—malignant glioma	0.000279	0.000355	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—ASMT—malignant glioma	0.000277	0.000352	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—GSTT1—malignant glioma	0.000271	0.000345	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00027	0.000344	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—BCAN—malignant glioma	0.000262	0.000334	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—BCAN—malignant glioma	0.00026	0.000331	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—IDH2—malignant glioma	0.000258	0.000328	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—IDH1—malignant glioma	0.000256	0.000325	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PTGS1—malignant glioma	0.000254	0.000323	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—SPHK1—malignant glioma	0.000248	0.000315	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PIK3CB—malignant glioma	0.000244	0.000311	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000243	0.000309	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CYP2C18—malignant glioma	0.000243	0.000308	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CYP2B6—malignant glioma	0.000242	0.000308	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PTGS2—malignant glioma	0.000242	0.000308	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—BCHE—malignant glioma	0.000236	0.000301	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—SLC5A5—malignant glioma	0.000233	0.000297	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—IDH1—malignant glioma	0.000222	0.000282	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—COX8A—malignant glioma	0.000215	0.000273	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—SPHK1—malignant glioma	0.000214	0.000273	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—IDH2—malignant glioma	0.000212	0.000269	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PTEN—malignant glioma	0.000211	0.000268	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CYP2C18—malignant glioma	0.00021	0.000267	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—IDH2—malignant glioma	0.00021	0.000267	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CYP2B6—malignant glioma	0.000199	0.000253	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000198	0.000252	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000198	0.000252	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000197	0.000251	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—GSTT1—malignant glioma	0.000196	0.000249	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—GSTP1—malignant glioma	0.000188	0.000239	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PTGS1—malignant glioma	0.000184	0.000234	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CAT—malignant glioma	0.000183	0.000233	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—ASMT—malignant glioma	0.000183	0.000232	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—IDH1—malignant glioma	0.000182	0.000231	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00018	0.00023	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—IDH1—malignant glioma	0.00018	0.000229	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—SPHK1—malignant glioma	0.000176	0.000224	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000175	0.000222	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000174	0.000222	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—NCOR1—malignant glioma	0.000173	0.00022	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CYP2C18—malignant glioma	0.000172	0.000219	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—BCAN—malignant glioma	0.000172	0.000218	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000171	0.000217	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—BCHE—malignant glioma	0.000171	0.000217	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—GSTT1—malignant glioma	0.00017	0.000216	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—SLC5A5—malignant glioma	0.000169	0.000215	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000161	0.000205	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PTGS1—malignant glioma	0.000159	0.000202	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000159	0.000202	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—PIK3CA—malignant glioma	0.000149	0.000189	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—BCHE—malignant glioma	0.000148	0.000188	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000147	0.000187	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—SLC5A5—malignant glioma	0.000146	0.000186	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000142	0.00018	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—CAV1—malignant glioma	0.000141	0.000179	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—GSTT1—malignant glioma	0.000139	0.000177	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—IDH2—malignant glioma	0.000138	0.000176	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000138	0.000176	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000138	0.000176	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000137	0.000174	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—GSTP1—malignant glioma	0.000136	0.000173	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CAT—malignant glioma	0.000132	0.000168	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PTGS1—malignant glioma	0.000131	0.000166	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CYP2B6—malignant glioma	0.00013	0.000165	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PTGS1—malignant glioma	0.00013	0.000165	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000129	0.000164	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PIK3CG—malignant glioma	0.000128	0.000163	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—NCOR1—malignant glioma	0.000125	0.000159	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PPARG—malignant glioma	0.000124	0.000158	CbGpPWpGaD
Rifapentine—CYP3A43—Metabolism—AKT1—malignant glioma	0.000122	0.000155	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—BCHE—malignant glioma	0.000122	0.000155	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—BCHE—malignant glioma	0.00012	0.000153	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—SLC5A5—malignant glioma	0.00012	0.000153	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000119	0.000152	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000119	0.000151	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—IDH1—malignant glioma	0.000119	0.000151	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—GSTP1—malignant glioma	0.000118	0.00015	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—SPHK1—malignant glioma	0.000115	0.000146	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CAT—malignant glioma	0.000115	0.000146	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PIK3CD—malignant glioma	0.000113	0.000144	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CYP2C18—malignant glioma	0.000113	0.000143	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000113	0.000143	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000111	0.000142	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—NCOR1—malignant glioma	0.000108	0.000138	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—CAV1—malignant glioma	0.000102	0.00013	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PIK3CB—malignant glioma	9.83e-05	0.000125	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PTGS2—malignant glioma	9.74e-05	0.000124	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.72e-05	0.000124	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—GSTP1—malignant glioma	9.67e-05	0.000123	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—GSTP1—malignant glioma	9.58e-05	0.000122	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CAT—malignant glioma	9.41e-05	0.00012	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CAT—malignant glioma	9.33e-05	0.000119	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PIK3CG—malignant glioma	9.28e-05	0.000118	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—GSTT1—malignant glioma	9.12e-05	0.000116	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PPARG—malignant glioma	8.95e-05	0.000114	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—NCOR1—malignant glioma	8.88e-05	0.000113	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—CAV1—malignant glioma	8.82e-05	0.000112	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—NCOR1—malignant glioma	8.81e-05	0.000112	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PTGS1—malignant glioma	8.55e-05	0.000109	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PTEN—malignant glioma	8.5e-05	0.000108	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.43e-05	0.000107	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PIK3CD—malignant glioma	8.16e-05	0.000104	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PIK3CG—malignant glioma	8.04e-05	0.000102	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—BCHE—malignant glioma	7.94e-05	0.000101	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.85e-05	9.98e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PPARG—malignant glioma	7.76e-05	9.86e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—CAV1—malignant glioma	7.24e-05	9.21e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—CAV1—malignant glioma	7.18e-05	9.13e-05	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PIK3CB—malignant glioma	7.11e-05	9.04e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PIK3CD—malignant glioma	7.06e-05	8.99e-05	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PTGS2—malignant glioma	7.04e-05	8.96e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.86e-05	8.72e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.6e-05	8.39e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.54e-05	8.32e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PPARG—malignant glioma	6.37e-05	8.1e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—GSTP1—malignant glioma	6.32e-05	8.04e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PPARG—malignant glioma	6.31e-05	8.03e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.16e-05	7.83e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CAT—malignant glioma	6.15e-05	7.82e-05	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PTEN—malignant glioma	6.14e-05	7.81e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PTGS2—malignant glioma	6.1e-05	7.76e-05	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.99e-05	7.63e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—NCOR1—malignant glioma	5.81e-05	7.39e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.8e-05	7.38e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.75e-05	7.31e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PTEN—malignant glioma	5.32e-05	6.77e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.05e-05	6.43e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.01e-05	6.37e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PTGS2—malignant glioma	5.01e-05	6.37e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PTGS2—malignant glioma	4.97e-05	6.32e-05	CbGpPWpGaD
Rifapentine—CYP3A7—Metabolism—AKT1—malignant glioma	4.9e-05	6.23e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—CAV1—malignant glioma	4.74e-05	6.02e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PTEN—malignant glioma	4.37e-05	5.56e-05	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—PIK3CA—malignant glioma	4.33e-05	5.51e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PTEN—malignant glioma	4.33e-05	5.51e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.31e-05	5.49e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PPARG—malignant glioma	4.16e-05	5.29e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.79e-05	4.82e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.75e-05	4.77e-05	CbGpPWpGaD
Rifapentine—CYP3A5—Metabolism—AKT1—malignant glioma	3.54e-05	4.5e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.3e-05	4.2e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PTGS2—malignant glioma	3.27e-05	4.17e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.08e-05	3.92e-05	CbGpPWpGaD
Rifapentine—CYP2C8—Metabolism—AKT1—malignant glioma	3.07e-05	3.9e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.05e-05	3.89e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PTEN—malignant glioma	2.86e-05	3.63e-05	CbGpPWpGaD
Rifapentine—CYP2D6—Metabolism—AKT1—malignant glioma	2.52e-05	3.2e-05	CbGpPWpGaD
Rifapentine—CYP2C9—Metabolism—AKT1—malignant glioma	2.5e-05	3.17e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.01e-05	2.56e-05	CbGpPWpGaD
Rifapentine—CYP3A4—Metabolism—AKT1—malignant glioma	1.65e-05	2.09e-05	CbGpPWpGaD
